These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 23574100)

  • 21. [Non-neurogenic lower urinary tract dysfunction].
    Skobejko-Włodarska L
    Pol Merkur Lekarski; 2008; 24 Suppl 4():131-7. PubMed ID: 18924526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gender differences in bladder control: from babies to elderly.
    Bauer RM; Huebner W
    World J Urol; 2013 Oct; 31(5):1081-5. PubMed ID: 23881351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of overactive bladder syndrome on the sexual quality of life in Korean young and middle aged women.
    Kim YH; Seo JT; Yoon H
    Int J Impot Res; 2005; 17(2):158-63. PubMed ID: 15510187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can we define and characterize the aging lower urinary tract?-ICI-RS 2015.
    Vahabi B; Wagg AS; Rosier PFWM; Rademakers KLJ; Denys MA; Pontari M; Lovick T; Valentini FA; Nelson PP; Andersson KE; Fry CH
    Neurourol Urodyn; 2017 Apr; 36(4):854-858. PubMed ID: 28444710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenesis of reduced or increased bladder sensation.
    Tsunoyama K; Sakakibara R; Yamaguchi C; Uchiyama T; Yamamoto T; Yamanishi T; Takahashi O; Sugiyama M; Kishi M; Ogawa E
    Neurourol Urodyn; 2011 Mar; 30(3):339-43. PubMed ID: 21305587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.
    Gacci M; Eardley I; Giuliano F; Hatzichristou D; Kaplan SA; Maggi M; McVary KT; Mirone V; Porst H; Roehrborn CG
    Eur Urol; 2011 Oct; 60(4):809-25. PubMed ID: 21726934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new experimental rat model of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: the testosterone-supplemented spontaneously hypertensive rat.
    Oudot A; Oger S; Behr-Roussel D; Caisey S; Bernabé J; Alexandre L; Giuliano F
    BJU Int; 2012 Nov; 110(9):1352-8. PubMed ID: 22448674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pathophysiological changes in the bladder obstructed by benign prostatic hyperplasia.
    Brading AF
    Br J Urol; 1994 Jul; 74(1):133. PubMed ID: 7519110
    [No Abstract]   [Full Text] [Related]  

  • 29. Defining and advancing education and conservative therapies of underactive bladder.
    Griebling TL; DuBeau CE; Kuchel G; Wilde MH; Lajiness M; Tomoe H; Diokno A; Vereecke A; Chancellor MB
    Int Urol Nephrol; 2014 Sep; 46 Suppl 1():S29-34. PubMed ID: 25238892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changing concepts of bladder regeneration.
    Kanematsu A; Yamamoto S; Ogawa O
    Int J Urol; 2007 Aug; 14(8):673-8. PubMed ID: 17681053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pregnancy and delivery in patients with surgically corrected congenital extrophy of the bladder, through the operations of the continent urinary derivation].
    Nikolov A; Markov P; Chanachev S
    Akush Ginekol (Sofiia); 2011; 50(5):60-3. PubMed ID: 22482163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Add-on fesoterodine for residual storage symptoms suggestive of overactive bladder in men receiving α-blocker treatment for lower urinary tract symptoms.
    Kaplan SA; Roehrborn CG; Gong J; Sun F; Guan Z
    BJU Int; 2012 Jun; 109(12):1831-40. PubMed ID: 21966995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Content validity of the Benign Prostatic Hyperplasia Impact Index (BII); a measure of how urinary trouble and problems associated with BPH may impact the patient.
    Kingery L; Martin ML; Naegeli AN; Khan S; Viktrup L
    Int J Clin Pract; 2012 Sep; 66(9):883-90. PubMed ID: 22897465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anatomic and functional changes of the lower urinary tract during pregnancy.
    FitzGerald MP; Graziano S
    Urol Clin North Am; 2007 Feb; 34(1):7-12. PubMed ID: 17145355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Underactive Bladder.
    Aggarwal H; Zimmern PE
    Curr Urol Rep; 2016 Mar; 17(3):17. PubMed ID: 26874529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of contemporary bladder management techniques on struvite calculi associated with spinal cord injury.
    Donnellan SM; Bolton DM
    BJU Int; 1999 Aug; 84(3):280-5. PubMed ID: 10468722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and burden of overactive bladder in the United States.
    Stewart WF; Van Rooyen JB; Cundiff GW; Abrams P; Herzog AR; Corey R; Hunt TL; Wein AJ
    World J Urol; 2003 May; 20(6):327-36. PubMed ID: 12811491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary bladder capacity. The clinical importance in children.
    Geist RW; Antolak SJ; Richardson EJ
    Minn Med; 1972 Feb; 55(2):100-3 passim. PubMed ID: 5059477
    [No Abstract]   [Full Text] [Related]  

  • 39. [Indicator of function of the urinary bladder].
    Gol'dberg VV
    Vestn Khir Im I I Grek; 1974 May; 112(5):128-9. PubMed ID: 4134521
    [No Abstract]   [Full Text] [Related]  

  • 40. Initial combined treatment with anticholinergics and α-blockers for men with lower urinary tract symptoms related to BPH and overactive bladder: a prospective, randomized, multi-center, double-blind, placebo-controlled study.
    Lee SH; Chung BH; Kim SJ; Kim JH; Kim JC; Lee JY
    Prostate Cancer Prostatic Dis; 2011 Dec; 14(4):320-5. PubMed ID: 21788967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.